QI
HAE icon

QS Investors’s Haemonetics HAE Stock Holding History

QS Investors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$588K Sell
8,815
-28,538
-76% -$2.02M 0.01% 675
2021
Q1 		$4.15M Sell
37,353
-90
-0.2% -$11.1K 0.05% 275
2020
Q4 		$4.45M Sell
37,443
-105
-0.3% -$11.3K 0.05% 245
2020
Q3 		$3.28M Sell
37,548
-38,900
-51% -$3.4M 0.04% 270
2020
Q2 		$6.85M Sell
76,448
-43,012
-36% -$4.34M 0.1% 175
2020
Q1 		$11.9M Buy
119,460
+100
+0.1% +$10.8K 0.19% 99
2019
Q4 		$13.8M Sell
119,360
-710
-0.6% -$85.9K 0.14% 108
2019
Q3 		$15.1M Hold
120,070
– – 0.17% 90
2019
Q2 		$14.4M Buy
120,070
+57,230
+91% +$5.63M 0.16% 88
2019
Q1 		$5.5M Buy
62,840
+17,130
+37% +$1.56M 0.06% 234
2018
Q4 		$4.57M Hold
45,710
– – 0.06% 241
2018
Q3 		$5.24M Buy
45,710
+44,327
+3,205% +$4.59M 0.05% 269
2018
Q2 		$124K Buy
1,383
+6
+0.4% +$507 ﹤0.01% 1358
2018
Q1 		$101K Hold
1,377
– – ﹤0.01% 1379
2017
Q4 		$80K Buy
1,377
+77
+6% +$4.05K ﹤0.01% 1408
2017
Q3 		$58K Hold
1,300
– – ﹤0.01% 1488
2017
Q2 		$51K Hold
1,300
– – ﹤0.01% 1522
2017
Q1 		$53K Buy
+1,300
New +$50.8K ﹤0.01% 1493
2016
Q3 		– Sell
-15
Closed -$1K – 1955
2016
Q2 		$1K Buy
15
+7
+88% +$212 ﹤0.01% 1632
2016
Q1 		$1K Hold
8
– – ﹤0.01% 1627
2015
Q4 		$1K Buy
+8
New +$259 ﹤0.01% 1653

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

QS Investors's HAE Position: Q2 2021 in Review

QS Investors reduced its Haemonetics (HAE) stake by 76% in Q2 2021, selling an estimated $2.02M and leaving 8,815 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #675.

QS Investors first reported a position in HAE in Q4 2015 and has held it in 21 quarters since. The position peaked at $15.1M in Q3 2019. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • QS Investors held 8,815 shares of Haemonetics worth $588K as of Q2 2021.
  • QS Investors sold 28,538 Haemonetics shares in Q2 2021, an estimated $2.02M.
  • Haemonetics made up 0.01% of QS Investors's portfolio in Q2 2021, its #675 holding.
  • QS Investors first reported a position in Haemonetics in Q4 2015 and has held it in 21 quarters since.
  • QS Investors's Haemonetics position peaked at $15.1M in Q3 2019.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.